Jo. Bohnhorst et al., Significantly depressed percentage of CD27+(memory) B cells among peripheral blood B cells in patients with primary Sjogren's syndrome, SC J IMMUN, 54(4), 2001, pp. 421-427
CD27 has been found to be expressed on somatically mutated B cells and is t
hus a positive marker for memory B cells in peripheral blood (PB). Since ab
normal immunogloblin (Ig) production is characteristic of the autoimmune di
seases primary Sjogren's syndrome (pSS) and rheumatoid arthritis (RA), we h
ave analyzed in detail the CD27 expression on PB B cell from these patient
groups. Staining of PB B cells with monoclonal antibodies (MoAb) specific f
or CD19 and CD27 revealed a significantly depressed percentage of CD27+ PB
B cells in patients with pSS (14.8 +/- 1.6%) compared to both healthy donor
s (31.3 +/- 4.7%, P = 0.005) and patients with RA (40.8 +/- 4.1%, P = 0.000
1). In addition, the percentages of both the IgD+CD27+ and the IgD-CD27+ B-
cell subpopulations were significantly lower in pSS patients compared to RA
patients and healthy donors. However, the relative proportion of IgD- and
IgD+ cells among the CD27+B cells were almost the same for the three groups
. Our data suggest a disturbance in the differentiation of peripheral B cel
ls and possibly a bias towards plasma cell differentiation, resulting in a
depressed percentage of CD27+ memory PB B cells in pSS. These results are p
otentially of pathological significance and of diagnostic value.